2-147915329-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001616.5(ACVR2A):āc.667A>Gā(p.Ile223Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000411 in 1,459,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000041 ( 0 hom. )
Consequence
ACVR2A
NM_001616.5 missense
NM_001616.5 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.72
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.12628275).
BS2
High AC in GnomAdExome4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACVR2A | NM_001616.5 | c.667A>G | p.Ile223Val | missense_variant | 5/11 | ENST00000241416.12 | NP_001607.1 | |
ACVR2A | NM_001278579.2 | c.667A>G | p.Ile223Val | missense_variant | 6/12 | NP_001265508.1 | ||
ACVR2A | NM_001278580.2 | c.343A>G | p.Ile115Val | missense_variant | 5/11 | NP_001265509.1 | ||
ACVR2A | XM_047446292.1 | c.343A>G | p.Ile115Val | missense_variant | 5/11 | XP_047302248.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACVR2A | ENST00000241416.12 | c.667A>G | p.Ile223Val | missense_variant | 5/11 | 1 | NM_001616.5 | ENSP00000241416.7 | ||
ACVR2A | ENST00000404590.1 | c.667A>G | p.Ile223Val | missense_variant | 6/12 | 1 | ENSP00000384338.1 | |||
ACVR2A | ENST00000535787.5 | c.343A>G | p.Ile115Val | missense_variant | 5/11 | 2 | ENSP00000439988.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250320Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135276
GnomAD3 exomes
AF:
AC:
1
AN:
250320
Hom.:
AF XY:
AC XY:
0
AN XY:
135276
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459622Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726086
GnomAD4 exome
AF:
AC:
6
AN:
1459622
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
726086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.667A>G (p.I223V) alteration is located in exon 5 (coding exon 5) of the ACVR2A gene. This alteration results from a A to G substitution at nucleotide position 667, causing the isoleucine (I) at amino acid position 223 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;.;B
Vest4
MutPred
Loss of ubiquitination at K226 (P = 0.0962);.;Loss of ubiquitination at K226 (P = 0.0962);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at